Results 41 to 50 of about 1,299 (139)

In Vitro Pharmacodynamic Studies of Activities of Ketolides HMR 3647 (Telithromycin) and HMR 3004 against Extracellular or Intracellular Helicobacter pylori

open access: yes, 2001
The pharmacodynamic properties of the ketolides HMR 3647 (telithromycin) and HMR 3004 were studied against Helicobacter pylori .
I. Gustafsson   +5 more
core   +1 more source

The antibiotic resistance crisis and the development of new antibiotics

open access: yesMicrobial Biotechnology, Volume 17, Issue 7, July 2024.
The current Lilliput review analyses the question whether scientific or economic hurdles prevented the registration of new antibiotics. Scientifically, substantial progress has been achieved over recent years. The lack of profitability for costly novel antibiotic development necessitates push and pull efforts of the public sector to complement what the
Harald Brüssow
wiley   +1 more source

The Natural Ketolides Methymycin and Pikromycin: Binding Sites, Modes of Action, Mechanisms of Resistance

open access: yes, 2015
Ketolides are promising new antimicrobials effective against a broad range of Gram-positive pathogens, due in part to the low propensity of these drugs to trigger the expression of resistance genes.
Mashal M. Almutairi (5638046)
core   +6 more sources

South African actinobacteria: A treasure trove of novel bioactive metabolites for drug discovery

open access: yesSouth African Journal of Science
Although South Africa is known as one of the most biodiverse countries in the world, based on its unique plants and animals, microorganisms have received much less attention.
Kojo S. Acquah   +2 more
doaj   +1 more source

Synthesis and Antibacterial Activity of 6-O-Arylbutynyl Ketolides with Improved Activity against Some Key Erythromycin-Resistant Pathogens

open access: yes, 2016
A series of novel 6-O-substituted homopropargyl ketolides was synthesized and evaluated against various erythromycin-resistant pathogens.
Angela M. Nilius (2531995)   +6 more
core   +1 more source

What is the role of microbial biotechnology and genetic engineering in medicine?

open access: yesMicrobiologyOpen, Volume 13, Issue 2, April 2024.
Microbial biotechnology, the technological application of microorganisms, has been instrumental in producing significant natural bioactive products. These include antibiotics, antifungals, anticancer drugs, antiparasitics, antivirals, immunosuppressants, toxoid vaccines, and therapeutic enzymes.
Fernando Santos‐Beneit
wiley   +1 more source

Synthesis of Novel 6,11-O-Bridged Bicyclic Ketolides via a Palladium-Catalyzed Bis-allylation

open access: yes, 2016
A bridging chemistry process was developed to form an ether bridge between 6-O and 11-O of erythromycin A via a tandem or stepwise palladium-catalyzed bis-π-allylation.
Ly Tam Phan (2701579)   +6 more
core   +1 more source

The energy landscape of the ribosome

open access: yesBiopolymers, Volume 115, Issue 2, March 2024.
Abstract The ribosome is a prototypical assembly that can be used to establish general principles and techniques for the study of biological molecular machines. Motivated by the fact that the dynamics of every biomolecule is governed by an underlying energy landscape, there has been great interest to understand and quantify ribosome energetics.
Sandra Byju   +2 more
wiley   +1 more source

Discovery of Azetidinyl Ketolides for the Treatment of Susceptible and Multidrug Resistant Community-Acquired Respiratory Tract Infections

open access: yes, 2016
Respiratory tract bacterial strains are becoming increasingly resistant to currently marketed macrolide antibiotics. The current alternative telithromycin (1) from the newer ketolide class of macrolides addresses resistance but is hampered by serious ...
Joseph B. Penzien (2201149)   +37 more
core   +1 more source

Intravenous azithromycin plus ceftriaxone followed by oral azithromycin for the treatment of inpatients with community-acquired pneumonia: an open-label, non-comparative multicenter trial

open access: yesBrazilian Journal of Infectious Diseases
Community-Acquired Pneumonia (CAP) is a major public health problem. In Brazil it has been estimated that 2,000,000 people are affected by CAP every year. Of those, 780,000 are admitted to hospital, and 30,000 have death as the outcome.
Fernando G. Rubio   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy